Primaquine for plasmodium vivax malaria treatment – authors' reply
Κύριοι συγγραφείς: | Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2020
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
ανά: Setyadi, A, κ.ά.
Έκδοση: (2019) -
Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
ανά: Watson, JA, κ.ά.
Έκδοση: (2022) -
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
ανά: Taylor, WRJ, κ.ά.
Έκδοση: (2023) -
The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
ανά: Thriemer, K, κ.ά.
Έκδοση: (2020) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
ανά: Luzzi, G, κ.ά.
Έκδοση: (1992)